259 related articles for article (PubMed ID: 34069132)
1. Fucoxanthin and Colorectal Cancer Prevention.
Terasaki M; Kubota A; Kojima H; Maeda H; Miyashita K; Kawagoe C; Mutoh M; Tanaka T
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069132
[TBL] [Abstract][Full Text] [Related]
2. Fucoxanthin Inhibits Development of Sigmoid Colorectal Cancer in a PDX Model With Alterations of Growth, Adhesion, and Cell Cycle Signals.
Terasaki M; Tsuruoka K; Tanaka T; Maeda H; Shibata M; Miyashita K; Kanemitsu Y; Sekine S; Takahashi M; Yagishita S; Hamada A
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):686-705. PubMed ID: 38035706
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NF-kappaB transcriptional activity enhances fucoxanthinol-induced apoptosis in colorectal cancer cells.
Tamura S; Narita T; Fujii G; Miyamoto S; Hamoya T; Kurokawa Y; Takahashi M; Miki K; Matsuzawa Y; Komiya M; Terasaki M; Yano T; Mutoh M
Genes Environ; 2019; 41():1. PubMed ID: 30693059
[TBL] [Abstract][Full Text] [Related]
4. Fucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte Cells.
Maeda H; Kanno S; Kodate M; Hosokawa M; Miyashita K
Mar Drugs; 2015 Aug; 13(8):4799-813. PubMed ID: 26248075
[TBL] [Abstract][Full Text] [Related]
5. Effects of CLIC4 on Fucoxanthinol-Induced Apoptosis in Human Colorectal Cancer Cells.
Yokoyama R; Kojima H; Takai R; Ohta T; Maeda H; Miyashita K; Mutoh M; Terasaki M
Nutr Cancer; 2021; 73(5):889-898. PubMed ID: 33703973
[TBL] [Abstract][Full Text] [Related]
6. Fucoxanthin Is a Potential Therapeutic Agent for the Treatment of Breast Cancer.
Lau TY; Kwan HY
Mar Drugs; 2022 May; 20(6):. PubMed ID: 35736173
[TBL] [Abstract][Full Text] [Related]
7. Reduction of HbA1c levels by fucoxanthin-enriched akamoku oil possibly involves the thrifty allele of uncoupling protein 1 (
Mikami N; Hosokawa M; Miyashita K; Sohma H; Ito YM; Kokai Y
J Nutr Sci; 2017; 6():e5. PubMed ID: 28620480
[TBL] [Abstract][Full Text] [Related]
8. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas.
Yamamoto K; Ishikawa C; Katano H; Yasumoto T; Mori N
Cancer Lett; 2011 Jan; 300(2):225-34. PubMed ID: 21078541
[TBL] [Abstract][Full Text] [Related]
9. Emerging Technologies to Extract Fucoxanthin from
Lourenço-Lopes C; Carreira-Casais A; Carperna M; Barral-Martinez M; Chamorro F; Jiménez-López C; Cassani L; Simal-Gandara J; Prieto MA
Mar Drugs; 2023 Apr; 21(5):. PubMed ID: 37233476
[TBL] [Abstract][Full Text] [Related]
10. Salivary Glycine Is a Significant Predictor for the Attenuation of Polyp and Tumor Microenvironment Formation by Fucoxanthin in AOM/DSS Mice.
Terasaki M; Masaka S; Fukada C; Houzaki M; Endo T; Tanaka T; Maeda H; Miyashita K; Mutoh M
In Vivo; 2019; 33(2):365-374. PubMed ID: 30804114
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effects of fucoxanthin and fucoxanthinol on colorectal cancer cell lines and colorectal cancer tissues.
Takahashi K; Hosokawa M; Kasajima H; Hatanaka K; Kudo K; Shimoyama N; Miyashita K
Oncol Lett; 2015 Sep; 10(3):1463-1467. PubMed ID: 26622691
[TBL] [Abstract][Full Text] [Related]
12. A Marine Carotenoid of Fucoxanthinol Accelerates the Growth of Human Pancreatic Cancer PANC-1 Cells.
Terasaki M; Takahashi S; Nishimura R; Kubota A; Kojima H; Ohta T; Hamada J; Kuramitsu Y; Maeda H; Miyashita K; Takahashi M; Mutoh M
Nutr Cancer; 2022; 74(1):357-371. PubMed ID: 33590779
[TBL] [Abstract][Full Text] [Related]
13. Anti-neoplastic effects of fucoxanthin and its deacetylated product, fucoxanthinol, on Burkitt's and Hodgkin's lymphoma cells.
Tafuku S; Ishikawa C; Yasumoto T; Mori N
Oncol Rep; 2012 Oct; 28(4):1512-8. PubMed ID: 22859062
[TBL] [Abstract][Full Text] [Related]
14. Dietary Fucoxanthin Induces Anoikis in Colorectal Adenocarcinoma by Suppressing Integrin Signaling in a Murine Colorectal Cancer Model.
Terasaki M; Ikuta M; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31905803
[TBL] [Abstract][Full Text] [Related]
15. Requirement of CLIC4 Expression in Human Colorectal Cancer Cells for Sensitivity to Growth Inhibition by Fucoxanthinol.
Yokoyama R; Kushibiki A; Yamada S; Kubota A; Kojima H; Ohta T; Hamada J; Maeda H; Mutoh M; Terasaki M
Cancer Genomics Proteomics; 2022; 19(4):428-444. PubMed ID: 35732323
[TBL] [Abstract][Full Text] [Related]
16. Fucoxanthin potentiates anoikis in colon mucosa and prevents carcinogenesis in AOM/DSS model mice.
Terasaki M; Iida T; Kikuchi F; Tamura K; Endo T; Kuramitsu Y; Tanaka T; Maeda H; Miyashita K; Mutoh M
J Nutr Biochem; 2019 Feb; 64():198-205. PubMed ID: 30530259
[TBL] [Abstract][Full Text] [Related]
17. Kinetic Extraction of Fucoxanthin from
Lourenço-Lopes C; Silva A; Garcia-Oliveira P; Soria-Lopez A; Echave J; Grosso C; Cassani L; Barroso MF; Simal-Gandara J; Fraga-Corral M; Prieto MA
Mar Drugs; 2023 Jul; 21(7):. PubMed ID: 37504945
[TBL] [Abstract][Full Text] [Related]
18. Optimization of fucoxanthin extraction obtained from natural by-products from
Yin S; Niu L; Shibata M; Liu Y; Hagiwara T
Front Nutr; 2022; 9():981176. PubMed ID: 36245524
[TBL] [Abstract][Full Text] [Related]
19. Health-Promoting Functions of the Marine Carotenoid Fucoxanthin.
Hosokawa M
Adv Exp Med Biol; 2021; 1261():273-284. PubMed ID: 33783750
[TBL] [Abstract][Full Text] [Related]
20. Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells.
Terasaki M; Mima M; Kudoh S; Endo T; Maeda H; Hamada J; Osada K; Miyashita K; Mutoh M
Oncol Rep; 2018 Jul; 40(1):414-424. PubMed ID: 29693702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
